Biosyent Stock Piotroski F Score

RX Stock  CAD 11.52  0.18  1.54%   
This module uses fundamental data of Biosyent to approximate its Piotroski F score. Biosyent F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Biosyent. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Biosyent financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Biosyent. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
  
Interest Debt Per Share is likely to climb to 0.01 in 2024, whereas Short and Long Term Debt Total is likely to drop slightly above 1.2 M in 2024. At this time, Biosyent's Net Income Per Share is fairly stable compared to the past year. Days Of Inventory On Hand is likely to climb to 376.99 in 2024, whereas Days Sales Outstanding is likely to drop 38.93 in 2024.
At this time, it appears that Biosyent's Piotroski F Score is Inapplicable. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
4.0
Piotroski F Score - Inapplicable
Current Return On Assets

Positive

Focus
Change in Return on Assets

Increased

Focus
Cash Flow Return on Assets

Positive

Focus
Current Quality of Earnings (accrual)

Decreasing

Focus
Asset Turnover Growth

Decrease

Focus
Current Ratio Change

Decrease

Focus
Long Term Debt Over Assets Change

N/A

Focus
Change In Outstending Shares

Increase

Focus
Change in Gross Margin

No Change

Focus

Biosyent Piotroski F Score Drivers

The critical factor to consider when applying the Piotroski F Score to Biosyent is to make sure Biosyent is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Biosyent's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Biosyent's financial numbers are properly reported.
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.740.7607
Fairly Down
Slightly volatile
Gross Profit Margin0.560.8103
Way Down
Very volatile
Total Current Liabilities5.8 M5.5 M
Sufficiently Up
Slightly volatile
Non Current Liabilities Total851.1 K1.2 M
Way Down
Slightly volatile
Total Assets43.6 M41.5 M
Sufficiently Up
Slightly volatile
Total Current Assets37.7 M35.9 M
Sufficiently Up
Slightly volatile

Biosyent F Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Biosyent's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Biosyent in a much-optimized way.

About Biosyent Piotroski F Score

F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.

Book Value Per Share

3.05

At this time, Biosyent's Book Value Per Share is fairly stable compared to the past year.

Biosyent Current Valuation Drivers

We derive many important indicators used in calculating different scores of Biosyent from analyzing Biosyent's financial statements. These drivers represent accounts that assess Biosyent's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Biosyent's important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap85.1M102.8M104.8M107.0M96.3M101.1M
Enterprise Value73.5M84.2M88.3M100.2M90.2M94.7M

About Biosyent Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Biosyent's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biosyent using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biosyent based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Biosyent Stock Analysis

When running Biosyent's price analysis, check to measure Biosyent's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biosyent is operating at the current time. Most of Biosyent's value examination focuses on studying past and present price action to predict the probability of Biosyent's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biosyent's price. Additionally, you may evaluate how the addition of Biosyent to your portfolios can decrease your overall portfolio volatility.